Nurix Therapeutics Announces Bexobrutideg Oral Presentation at the 2026 European Hematology Association Congress
Go back to Nurix Therapeutics Announces Bexobrutideg Oral Presentation at the 2026 European Hematology Association Congress| (NASDAQ: NRIX) | Delayed: 18.28 +0.73 (4.16%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $17.55 | 52 Week High | $ | |||
| Open | $17.83 | 52 Week Low | $ | |||
| Day High | $18.64 | P/E | N/A | |||
| Day Low | $17.83 | EPS | $ | |||
| Volume | 262,349 | |||||

